News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Kaken Pharmaceuticals Reveals Results From Early Phase II Clinical Trial On KCB-1D



10/19/2005 5:11:54 PM

Kaken Pharmaceutical has announced that it has completed an early phase II clinical trial of KCB-1D, a drug candidate for the treatment of periodontitis, and detailed results were presented at the 47th Annual Meeting in Autumn of the Japanese Society of Periodontology (Sendai, October 5) by Osaka University Professor Shinya Murakami.

Read at JCN Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES